Estados financieros detallados de Myomo, Inc. (MYO): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Myomo, Inc. registró ingresos de $40.9M en el último ejercicio fiscal, con un CAGR de 5 años del 40.1%.
Márgenes de los últimos 12 meses: margen bruto 68.4%, margen operativo -27.1%, margen neto -33.5%.
Al precio actual de $1.29, MYO presenta beneficios negativos (P/E no significativo) y un ROE del -142.02%. La capitalización bursátil es de $50M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $1.1M | $1.6M | $2.4M | $3.8M | $7.6M | $13.9M | $15.6M | $19.2M | $32.6M | $40.9M |
| Coste de Ventas | $282164 | $505280 | $728279 | $917623 | $2.6M | $3.5M | $5.3M | $6.1M | $9.4M | $14.0M |
| Beneficio Bruto | $821113 | $1.1M | $1.7M | $2.9M | $5.0M | $10.3M | $10.3M | $13.2M | $23.2M | $26.9M |
| I+D | $1.1M | $1.8M | $1.8M | $2.2M | $1.7M | $2.6M | $2.5M | $2.6M | $4.8M | $6.9M |
| Generales y Administrativos | $3.0M | $5.8M | $10.4M | $11.6M | $13.8M | $18.0M | $18.4M | $18.8M | $24.6M | $34.3M |
| Gastos Operativos | $4.1M | $7.6M | $12.2M | $13.7M | $15.5M | $20.6M | $20.9M | $21.4M | $29.4M | $41.3M |
| Beneficio Operativo | -$3.3M | -$6.5M | -$10.5M | -$10.8M | -$10.5M | -$10.3M | -$10.7M | -$8.2M | -$6.2M | -$14.4M |
| EBITDA | -$3.3M | -$6.5M | -$10.5M | -$10.7M | -$11.0M | -$9.9M | -$10.1M | -$7.5M | -$5.0M | -$12.4M |
| Gastos por Intereses | $342020 | $358916 | $358916 | $113631 | $474709 | 0 | 0 | 0 | 0 | $927800 |
| Beneficio Antes de Impuestos | -$3.6M | -$12.1M | -$10.3M | -$10.7M | -$11.6M | -$10.3M | -$10.7M | -$8.0M | -$5.8M | -$15.1M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | $88928 | $69937 | $156002 | $365617 | $504532 |
| Beneficio Neto | -$3.6M | -$12.1M | -$10.3M | -$10.7M | -$11.6M | -$10.4M | -$10.7M | -$8.1M | -$6.2M | -$15.6M |
| BPA | $-0.56 | $-84.05 | $-25.18 | $-19.20 | $-3.62 | $-1.78 | $-1.52 | $-0.28 | $-0.16 | $-0.37 |
| BPA Diluido | $-0.56 | $-84.05 | $-25.15 | $-19.20 | $-3.62 | $-1.78 | $-1.52 | $-0.28 | $-0.16 | $-0.37 |
| Acciones en Circulación (Diluidas) | $6.4M | $143927 | $410152 | $553787 | $3.3M | $5.8M | $7.1M | $29.5M | $37.8M | $41.9M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $10.1M | $11.4M | $10.1M | $11.7M |
| Beneficio Bruto | $6.4M | $7.8M | $6.9M | $8.4M |
| Beneficio Operativo | -$3.5M | -$2.8M | -$3.2M | -$2.3M |
| EBITDA | -$3.1M | -$2.5M | -$2.3M | -$3.5M |
| Beneficio Neto | -$3.7M | -$3.8M | -$3.0M | -$4.0M |
| BPA | $-0.09 | $-0.09 | $-0.07 | $-0.09 |
| BPA Diluido | $-0.09 | $-0.09 | $-0.07 | $-0.09 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $797174 | $13.0M | $6.5M | $4.5M | $12.2M | $15.5M | $5.3M | $6.9M | $24.4M | $14.1M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $2.0M | $492990 | $4.3M |
| Cuentas por Cobrar | $114506 | $297039 | $382258 | $424287 | $924916 | $2.0M | $1.9M | $2.4M | $3.8M | $4.1M |
| Inventario | $82435 | $201155 | $256149 | $439533 | $707114 | $808308 | $1.4M | $1.8M | $3.2M | $3.1M |
| Activos Corrientes | $1.1M | $13.8M | $7.9M | $6.1M | $14.4M | $19.1M | $9.2M | $13.7M | $32.8M | $27.6M |
| Inmovilizado Material | $21563 | $77150 | $187513 | $154972 | $263807 | $908195 | $703026 | $839348 | $8.9M | $6.7M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.6M |
| Activos Totales | $1.7M | $14.0M | $8.3M | $6.6M | $14.7M | $20.1M | $10.2M | $14.6M | $42.2M | $38.6M |
| Cuentas por Pagar | $311085 | $264890 | $426727 | $450101 | $180499 | $723352 | $569681 | $1.1M | $1.2M | $1.5M |
| Deuda a Corto | $2.1M | 0 | 0 | $1.8M | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $3.0M | $1.5M | $1.9M | $3.9M | $2.9M | $4.3M | $3.6M | $5.5M | $10.2M | $8.3M |
| Deuda a Largo | $3.4M | 0 | 0 | $888961 | 0 | 0 | 0 | 0 | 0 | $11.2M |
| Pasivos Totales | $19.2M | $1.5M | $1.9M | $4.8M | $3.1M | $4.7M | $3.8M | $5.6M | $17.5M | $27.2M |
| Reservas | -$22.9M | -$35.0M | -$45.3M | -$56.1M | -$67.7M | -$78.1M | -$88.8M | -$96.9M | -$103.1M | -$118.7M |
| Patrimonio Neto | -$17.5M | $12.4M | $6.4M | $1.8M | $11.6M | $15.4M | $6.4M | $9.0M | $24.7M | $11.4M |
| Deuda Total | $5.5M | 0 | 0 | $2.7M | $173437 | $735002 | $553908 | $601303 | $8.1M | $19.4M |
| Deuda Neta | $4.7M | -$13.0M | -$6.5M | -$1.8M | -$12.1M | -$14.8M | -$4.8M | -$8.3M | -$16.8M | $988630 |
| Capital Circulante | -$1.9M | $12.4M | $6.0M | $2.3M | $11.6M | $14.8M | $5.6M | $8.2M | $22.6M | $19.2M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $12.6M | $14.1M | $11.4M | $11.2M |
| Activos Totales | $34.1M | $38.6M | $36.8M | $35.3M |
| Pasivos Totales | $19.5M | $27.2M | $27.8M | $29.5M |
| Patrimonio Neto | $14.6M | $11.4M | $9.0M | $5.8M |
| Deuda Total | $12.3M | $19.4M | $19.0M | $20.1M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$3.6M | -$12.1M | -$10.3M | -$10.7M | -$11.6M | -$10.4M | -$10.7M | -$8.1M | -$6.2M | -$15.6M |
| Amortizaciones | $7731 | $11415 | $69682 | $95124 | $108670 | $335963 | $542627 | $517681 | $776971 | $2.0M |
| Compensación en Acciones | $94094 | $279508 | $814666 | $907993 | $614302 | $1.1M | $1.2M | $1.1M | $874438 | $2.1M |
| Cambio en Capital Circulante | $307180 | $505967 | -$186570 | -$550006 | $848915 | -$585498 | -$1.4M | $293211 | $1.3M | -$3.9M |
| Flujo de Caja Operativo | -$3.2M | -$6.2M | -$9.6M | -$10.3M | -$9.0M | -$9.5M | -$10.2M | -$6.2M | -$3.3M | -$14.5M |
| Inversiones (CapEx) | -$1865 | -$67002 | -$126867 | -$51991 | -$45752 | -$326462 | -$111793 | -$145816 | -$1.4M | -$1.7M |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | -$199000 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | -$74213 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$3.2M | -$6.2M | -$9.7M | -$10.4M | -$9.1M | -$9.9M | -$10.3M | -$6.3M | -$4.7M | -$16.3M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$1.8M | -$1.1M | -$2.2M | -$1.9M |
| Inversiones (CapEx) | -$1.1M | -$670688 | -$327804 | $327804 |
| Flujo de Caja Libre | -$2.9M | -$1.8M | -$2.5M | -$1.6M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $583990 | $564959 | $597248 | -$597248 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +41.3% | +56.8% | +57.0% | +97.6% | +82.7% | +12.3% | +23.7% | +69.2% | +25.7% |
| Crecimiento Beneficio Neto (anual) | | -234.5% | +14.7% | -3.8% | -7.9% | +10.3% | -3.4% | +24.0% | +24.1% | -151.9% |
| Crecimiento BPA (anual) | | -14908.9% | +70.0% | +23.7% | +81.1% | +50.8% | +14.6% | +81.6% | +42.9% | -131.2% |
| Cambio en Acciones (anual) | | -97.8% | +185.0% | +35.0% | +501.3% | +75.1% | +20.9% | +318.3% | +28.0% | +10.8% |
| Crecimiento FCF (anual) | | -94.1% | -56.5% | -6.8% | +12.7% | -8.8% | -4.8% | +38.9% | +26.4% | -249.5% |
| Margen Bruto | 74.4% | 67.6% | 70.2% | 76.1% | 65.7% | 74.4% | 65.9% | 68.5% | 71.2% | 65.7% |
| Margen Operativo | -296.8% | -420.1% | -430.8% | -281.3% | -138.5% | -74.1% | -68.6% | -42.8% | -19.1% | -35.2% |
| Margen EBITDA | -296.1% | -419.3% | -427.9% | -278.8% | -144.8% | -71.8% | -65.0% | -38.8% | -15.5% | -30.2% |
| Margen Neto | -327.8% | -776.0% | -422.1% | -279.1% | -152.5% | -74.9% | -68.9% | -42.3% | -19.0% | -38.1% |
| Margen FCF | -290.5% | -399.0% | -398.2% | -270.8% | -119.7% | -71.3% | -66.5% | -32.8% | -14.3% | -39.7% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.9% | -0.7% | -2.0% | -6.3% | -3.3% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.50 | $-43.22 | $-23.73 | $-18.77 | $-2.73 | $-1.69 | $-1.47 | $-0.21 | $-0.12 | $-0.39 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $6.4M | $143927 | $409746 | $553787 | $3.3M | $5.8M | $7.1M | $29.1M | $37.8M | $41.9M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -142.02% |
| Rentabilidad sobre capital invertido | -45.17% |
| Rentabilidad sobre activos | -41.05% |
| Margen bruto | 68.35% |
| Margen operativo | -27.05% |
| Margen neto | -33.53% |
Salud financiera
| Deuda / Patrimonio | 3.44 |
| Ratio corriente | 2.31 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -3.04 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -396.43 | -1.34 | -1.72 | -0.47 | -1.86 | -3.85 | -0.34 | -17.89 | -40.25 | -2.46 |
| P/VC | -81.18 | 1.30 | 2.75 | 2.74 | 1.94 | 2.59 | 0.57 | 16.22 | 9.84 | 3.34 |
| P/V | 1289.83 | 10.39 | 7.24 | 1.30 | 2.96 | 2.88 | 0.23 | 7.58 | 7.47 | 0.93 |
| Margen Bruto | 74.4% | 67.6% | 70.2% | 76.1% | 65.7% | 74.4% | 65.9% | 68.5% | 71.2% | 65.7% |
| Margen Operativo | -296.8% | -420.1% | -430.8% | -281.3% | -138.5% | -74.1% | -68.6% | -42.8% | -19.1% | -35.2% |
| Margen Neto | -327.8% | -776.0% | -422.1% | -279.1% | -152.5% | -74.9% | -68.9% | -42.3% | -19.0% | -38.1% |